ADAM: A clinical decision support system to standardise management of the maintenance treatment phase of acute lymphoblastic leukaemia
The Assisted Dose Advice System for ALL (acute lymphoblastic leukemia) Maintenance is a web-based clinical decision support system developed to optimize and standardize management of acute lymphoblastic leukemia.
Project start date : 24/07/2021
Last updated : 21/03/2024
Beneficiary country : India
What problem does the initiative address ?
The purpose of the ADAM initiative is to optimize and standardize treatment during the maintenance treatment phase of acute lymphoblastic leukemia (ALL). Treatment during this phase requires practitioners to modify drug doses periodically through the 96 weeks (~2 years) of treatment to ensure that patients are treated with the highe...
Detailed description of the initiative
(Figures cited in the write-up below are uploaded in the Gallery photo section of the Media tab)
A ssisted Dose A dvice
What is the proposed solution added value ?
The Covid-19 pandemic compelled treatment centers to introduce remote monitoring of ALL maintenance, using e-mail and newly-built apps to exchange information on blood counts and drug dose advice. There is at present no system similar to ADAM that is designed to support and standardize dose adjustment decisions and practice in ALL maintenance. The availability of longitudinal clinical data for dose adjustment decisions and ADAM’s decision assist...
130
Number of beneficiaries since launch
4 Full-Time equivalents
9 Employees
N/C Volunteers
1 Service providers




130
Number of beneficiaries since launch
Target audience
- Healthcare professionals and structures (hospitals, healthcare centres/clinics, health networks)
- Children - adolescents (ages 6-18)
- Young children (0-5 years)
- Patient family/entourage
Project objectives
- Decreased mortality
- Decreased morbidity
- Improved treatment
- Other (please explain)
Materials used
- Computer
- Other (specify)
Technologies used
- Internet
Offline use
Yes
Open source
No
Open data
No
Independent evaluation
No
About the sponsor
Tata Translational Cancer Research Centre
Tata Medical Center, Kolkata (TMC) , a not-for-profit specialist cancer hospital, in partnership with Tata Consultancy Services (TCS) , an Indian multinational consulting company specializing in information technology and management, ad...
Sector : Academic entities (Universities, research laboratories, etc)
Country of origin : India
Contact : Sponsor website Project website
Partners
-
Tata Consultancy Services
Industrial (Startups, enterprises, etc.)
-
Indian Pediatric Hematology Oncology Group
Institutions (Communities, public authorities, NGOs, foundations, etc.)